DK1375512T3 - Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætninger - Google Patents
Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætningerInfo
- Publication number
- DK1375512T3 DK1375512T3 DK02291551T DK02291551T DK1375512T3 DK 1375512 T3 DK1375512 T3 DK 1375512T3 DK 02291551 T DK02291551 T DK 02291551T DK 02291551 T DK02291551 T DK 02291551T DK 1375512 T3 DK1375512 T3 DK 1375512T3
- Authority
- DK
- Denmark
- Prior art keywords
- approved
- immunogenic compositions
- measles virus
- vaccine strain
- virus vaccine
- Prior art date
Links
- 239000002299 complementary DNA Substances 0.000 title abstract 3
- 230000002163 immunogen Effects 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 229940124862 Measles virus vaccine Drugs 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 230000002458 infectious effect Effects 0.000 title 1
- 241000712079 Measles morbillivirus Species 0.000 abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/115—Paramyxoviridae, e.g. parainfluenza virus
- C07K14/12—Mumps virus; Measles virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18421—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18441—Use of virus, viral particle or viral elements as a vector
- C12N2760/18443—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10211—Podoviridae
- C12N2795/10241—Use of virus, viral particle or viral elements as a vector
- C12N2795/10243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02291551A EP1375512B1 (en) | 2002-06-20 | 2002-06-20 | Infectious cDNA of an approved vaccine strain of measles virus. Use for immunogenic compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1375512T3 true DK1375512T3 (da) | 2009-10-26 |
Family
ID=29716946
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02291551T DK1375512T3 (da) | 2002-06-20 | 2002-06-20 | Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætninger |
| DK10184511.3T DK2311853T3 (da) | 2002-06-20 | 2003-06-20 | Infektiøst cDNA af en godkendt vaccinestamme for mæslingevirus. Anvendelse for immunogene sammensætninger |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK10184511.3T DK2311853T3 (da) | 2002-06-20 | 2003-06-20 | Infektiøst cDNA af en godkendt vaccinestamme for mæslingevirus. Anvendelse for immunogene sammensætninger |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US9005961B2 (da) |
| EP (5) | EP2110382A1 (da) |
| KR (1) | KR101227128B1 (da) |
| CN (1) | CN100577683C (da) |
| AT (1) | ATE437175T1 (da) |
| AU (1) | AU2003266950A1 (da) |
| BR (1) | BRPI0312173B8 (da) |
| CA (1) | CA2489052C (da) |
| CY (1) | CY1109506T1 (da) |
| DE (1) | DE60233038D1 (da) |
| DK (2) | DK1375512T3 (da) |
| ES (2) | ES2330309T3 (da) |
| HK (1) | HK1061568A1 (da) |
| PT (1) | PT1375512E (da) |
| WO (1) | WO2004000876A1 (da) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1201750A1 (en) * | 2000-10-26 | 2002-05-02 | Genopoietic | Synthetic viruses and uses thereof |
| DK1375670T3 (da) * | 2002-06-20 | 2013-09-23 | Pasteur Institut | Rekombinante mæslingevira, der udtrykker epitoper af RNA-viras antigener, samt anvendelse af de rekombinante vira til fremstilling af vaccinesammensætninger |
| ES2330309T3 (es) * | 2002-06-20 | 2009-12-09 | Institut Pasteur | Adnc infeccioso de una cepa de vacuna aprobada de virus del sarampion. uso para composiciones inmunogenicas. |
| CA2432738A1 (en) | 2003-02-26 | 2004-08-26 | Philippe Despres | New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| WO2009005917A2 (en) * | 2007-05-29 | 2009-01-08 | Vical Incorporated | Methods of treating measles infectious disease in mammals |
| MX2010005701A (es) * | 2007-11-26 | 2010-08-31 | London School Of Hygiene & Tro | Metodo para producir cepa viral vacunal de un virus de la familia reoviridae. |
| EP2085479A1 (en) * | 2008-01-31 | 2009-08-05 | Institut Pasteur | Reverse genetics of negative-strand rna viruses in yeast |
| EP2420242A1 (en) | 2010-08-20 | 2012-02-22 | Lauer, Ulrich M. | Oncolytic measles virus |
| US20130122038A1 (en) | 2011-11-14 | 2013-05-16 | The United States Of America As Represented By The Secretary Of The Department | Heterologous prime-boost immunization using measles virus-based vaccines |
| EP2712871A1 (en) * | 2012-09-27 | 2014-04-02 | Institut Pasteur | Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications |
| EP2759301A1 (en) | 2013-01-24 | 2014-07-30 | Institut Pasteur | Use of a genetically modified infectious measles virus with enhanced pro-apoptotic properties (MV-DeltaC virus) |
| WO2015092710A1 (en) | 2013-12-19 | 2015-06-25 | Glaxosmithkline Biologicals, S.A. | Contralateral co-administration of vaccines |
| EP2959915A1 (en) | 2014-06-23 | 2015-12-30 | Institut Pasteur | A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection |
| EP3103474A1 (en) * | 2015-06-12 | 2016-12-14 | Institut Pasteur | Live recombinant measles-m2 virus and its use in eliciting immunity against influenza viruses |
| EP3184119A1 (en) | 2015-12-23 | 2017-06-28 | Themis Bioscience GmbH | Chromatography based purification strategies for measles scaffold based viruses |
| JP6949468B2 (ja) * | 2016-10-17 | 2021-10-13 | ルプレヒト−カールス−ウニベルジテート ハイデルベルク | 腫瘍抗原をコードする麻疹ウイルス |
| US11351246B2 (en) | 2017-05-09 | 2022-06-07 | Invectys SAS | Recombinant measles vaccine expressing hTERT |
| EP3412307A1 (en) | 2017-06-07 | 2018-12-12 | Institut Pasteur | Recombinant measles virus expressing zika virus proteins and their applications |
| SG11202004234SA (en) | 2017-11-09 | 2020-06-29 | Pasteur Institut | A zika virus chimeric polyepitope comprising non-structural proteins and its use in an immunogenic composition |
| AU2018392826A1 (en) * | 2017-12-21 | 2020-06-18 | Centre National De La Recherche Scientifique | Lassa vaccine |
| CN111218475A (zh) * | 2018-11-23 | 2020-06-02 | 成都生物制品研究所有限责任公司 | 一种拯救麻疹Schwarz/Moraten疫苗株的系统和方法 |
| CN116472279A (zh) * | 2020-02-13 | 2023-07-21 | 巴斯德研究院 | 麻疹载体covid-19免疫原性组合物和疫苗 |
| EP3865180A1 (en) * | 2020-02-13 | 2021-08-18 | Institut Pasteur | Live recombinant measles virus expressing coronavirus antigens - its use in eliciting immunity against coronaviruses |
| EP3936517A1 (en) | 2020-07-08 | 2022-01-12 | Institut Pasteur | An improved measles virus vaccine vector based on multiple tandem additional transcription units |
| JP2024502658A (ja) | 2021-01-13 | 2024-01-22 | ヴィロキシ | 麻疹－ｈｉｖ又は麻疹－ｈｔｌｖワクチン |
| CN113293148B (zh) * | 2021-03-10 | 2022-10-25 | 上海青赛生物科技有限公司 | 一种h基因替换的嵌合麻疹减毒株的构建 |
| WO2022195900A1 (ja) * | 2021-03-15 | 2022-09-22 | 国立大学法人東京大学 | 組換え麻疹ウイルス |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU7007491A (en) | 1990-02-02 | 1991-08-08 | Schweiz. Serum- & Impfinstitut Bern | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses |
| JP3045581B2 (ja) | 1991-10-14 | 2000-05-29 | 社団法人北里研究所 | 麻疹ワクチンウイルス株同定方法 |
| DE69510207T3 (de) * | 1995-08-09 | 2007-02-15 | Schweiz. Serum- & Impfinstitut Bern | Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren |
| EP0932684A2 (en) * | 1996-09-27 | 1999-08-04 | American Cyanamid Company | 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales |
| IL131600A0 (en) | 1997-02-28 | 2001-01-28 | Ora Vax Inc | Chimeric flavivirus vaccines |
| BRPI9701774B8 (pt) * | 1997-04-11 | 2015-09-29 | Fundação Oswaldo Cruz Fiocruz | cdna mutante e infeccioso do vírus da febre amarela, constructo de dna, vírus recombinante de febre amarela e vacina para humanos contra infecções de febre amarela. |
| US6410023B1 (en) * | 1997-05-23 | 2002-06-25 | United States Of America | Recombinant parainfluenza virus vaccines attenuated by deletion or ablation of a non-essential gene |
| CN1177927C (zh) * | 1998-03-26 | 2004-12-01 | 惠氏控股有限公司 | 引起麻疹病毒或人呼吸道合胞病毒亚组b减毒的突变 |
| ATE499438T1 (de) * | 1998-06-03 | 2011-03-15 | Wyeth Corp | Verfahren zum retten der rna-viren |
| US6146642A (en) | 1998-09-14 | 2000-11-14 | Mount Sinai School Of Medicine, Of The City University Of New York | Recombinant new castle disease virus RNA expression systems and vaccines |
| MXPA02001177A (es) | 1999-08-02 | 2002-07-02 | Wyeth Corp | Recuperacion del virus de las paperas del acido desoxirribonucleico recombinante. |
| ATE420189T1 (de) * | 2000-04-28 | 2009-01-15 | St Jude Childrens Res Hospital | Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus |
| ES2330309T3 (es) | 2002-06-20 | 2009-12-09 | Institut Pasteur | Adnc infeccioso de una cepa de vacuna aprobada de virus del sarampion. uso para composiciones inmunogenicas. |
| DK1375670T3 (da) * | 2002-06-20 | 2013-09-23 | Pasteur Institut | Rekombinante mæslingevira, der udtrykker epitoper af RNA-viras antigener, samt anvendelse af de rekombinante vira til fremstilling af vaccinesammensætninger |
| CA2432738A1 (en) | 2003-02-26 | 2004-08-26 | Philippe Despres | New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| CA2508266A1 (fr) | 2005-06-20 | 2006-12-20 | Institut Pasteur | Polypeptides chimeriques et leurs applications therapeutiques contre une infection a flaviviridae |
| ES2423518T3 (es) | 2006-12-22 | 2013-09-20 | Institut Pasteur | Células y metodología para generar virus de ARN de cadena de sentido negativo no segmentada |
| CN106377767A (zh) * | 2008-05-26 | 2017-02-08 | 卡迪拉保健有限公司 | 麻疹‑人乳头瘤组合疫苗 |
| UA104180C2 (uk) * | 2009-05-05 | 2014-01-10 | Каділа Хелткере Лімітед | Комбінована вакцина проти кору та малярії |
-
2002
- 2002-06-20 ES ES02291551T patent/ES2330309T3/es not_active Expired - Lifetime
- 2002-06-20 PT PT02291551T patent/PT1375512E/pt unknown
- 2002-06-20 DE DE60233038T patent/DE60233038D1/de not_active Expired - Lifetime
- 2002-06-20 AT AT02291551T patent/ATE437175T1/de active
- 2002-06-20 EP EP09165802A patent/EP2110382A1/en not_active Withdrawn
- 2002-06-20 DK DK02291551T patent/DK1375512T3/da active
- 2002-06-20 EP EP02291551A patent/EP1375512B1/en not_active Expired - Lifetime
-
2003
- 2003-06-20 CA CA2489052A patent/CA2489052C/en not_active Expired - Lifetime
- 2003-06-20 AU AU2003266950A patent/AU2003266950A1/en not_active Abandoned
- 2003-06-20 KR KR1020047020803A patent/KR101227128B1/ko active IP Right Grant
- 2003-06-20 EP EP10184511.3A patent/EP2311853B1/en not_active Expired - Lifetime
- 2003-06-20 WO PCT/EP2003/007145 patent/WO2004000876A1/en not_active Application Discontinuation
- 2003-06-20 EP EP08169719A patent/EP2065393A1/en not_active Withdrawn
- 2003-06-20 ES ES10184511.3T patent/ES2663224T3/es not_active Expired - Lifetime
- 2003-06-20 EP EP03747858A patent/EP1513872A1/en not_active Ceased
- 2003-06-20 CN CN03814471A patent/CN100577683C/zh not_active Expired - Lifetime
- 2003-06-20 BR BRPI0312173A patent/BRPI0312173B8/pt active IP Right Grant
- 2003-06-20 DK DK10184511.3T patent/DK2311853T3/da active
-
2004
- 2004-06-16 HK HK04104400.2A patent/HK1061568A1/xx not_active IP Right Cessation
- 2004-12-17 US US11/013,786 patent/US9005961B2/en active Active
-
2008
- 2008-07-24 US US12/219,570 patent/US9005925B2/en active Active
-
2009
- 2009-09-18 CY CY20091100970T patent/CY1109506T1/el unknown
-
2015
- 2015-03-24 US US14/667,088 patent/US9701944B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1375512T3 (da) | Infektiös cDNA af en godkendt vaccinestamme af mæslingevirus. Anvendelse til immunogene sammensætninger | |
| DK1487485T3 (da) | Imidazoquinolinadjuvanser til DNA-vacciner | |
| EA200501890A1 (ru) | Вирусы гриппа высокого титра для приготовления вакцин и генной терапии | |
| CY1119265T1 (el) | Κατασκευες νανοσωματων τρισθενους αντι ανθρωπινου αναπνευστικου συγκυτιακου ιου (hrsv) για την προληψη και/ή θεραπεια λοιμωξεων της αναπνευστικης οδου | |
| DK0702085T3 (da) | Rekombinant infektiøs ikke-segmenteret negativ-strenget RNA-virus | |
| CY1107146T1 (el) | Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad) | |
| ATE527281T1 (de) | Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte | |
| ATE430207T1 (de) | Genomische sequenzen von neisseria und verfahren zu ihrer verwendung | |
| MA30581B1 (fr) | Vaccin viral recombinant | |
| WO2009026465A3 (en) | Composition and methods of making and using influenza proteins | |
| ATE419369T1 (de) | Chimäre mensch-rinder respiratory syncytial virus vakzinen | |
| EA200600403A1 (ru) | Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки | |
| DK1831239T3 (da) | Fremgangsmåde til fremstilling af 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta-bismethylen-17alpha-pregn-4-en-3-on-21-carboxylsyre-lambda-lacton og nøgle-mellemprodukter til denne fremgangsmåde | |
| DK1356822T3 (da) | Farmaceutiske sammensætninger, der forøger immunogeniteten af svagt immunogene antigener | |
| ATE420191T1 (de) | Promotoren zur expression im modifizierten vacciniavirus ankara | |
| WO2005011571A3 (en) | Hepatitis virus core proteins as vaccine platforms and methods of use thereof | |
| ATE420658T1 (de) | Imidazoquinolinamine als adjuvantien für hiv dna vakzine | |
| FR2829498B1 (fr) | Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins | |
| DK1602360T3 (da) | Fremgangsmåde til opnåelse af sneglestrukturer, vaccinesammensætninger, adjuvanser og mellemprodukter dertil | |
| DK1383796T3 (da) | Neurovirulent stamme af viruset West Nile og anvendelser heraf | |
| ATE447008T1 (de) | Rre und cte umfassende gentechnische konstrukte und zusammensetzungen und verwendungen davon | |
| MX2019014819A (es) | Plásmido para inserción simplificada de secuencias cortas de adn en un cistrón que codifica para una proteína de cápside potyviral y método de aplicación. | |
| CY1113749T1 (el) | Συνθεσεις εμβολιων dna και μεθοδοι χρησης τους | |
| NO20042505L (no) | Ekspresjons-vektorer | |
| CY1114309T1 (el) | Εμβολιο ροταϊου |